Epivir
Product Images NDC 53808-0245
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Epivir (NDC 53808-0245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To Age (6bfd5b3e 9971 46ce 80d5 3be4709734e1 02)
Figure 2. Virologic Response Through Week 48, Epv20001ab (intent-to-treat) (6bfd5b3e 9971 46ce 80d5 3be4709734e1 03)
Epivir 300mg Label (Epivir 300mg(glaxosmith))
Epivir 150mg Label (Epivir150mg(glaxowellcom))
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.